Ellen Lubman

Ellen Lubman

Direktör/Styrelseledamot på
GeneCentric Therapeutics, Inc.
50 år
Health Technology
Consumer Services
Finance

Profil

Ellen A. Lubman is currently Director at GeneCentric Therapeutics, Inc., Director at Gilda's Club New York City, Inc., Director at Intrepida Bio, Inc., and Independent Director at Reunion Neuroscience, Inc. since 2021.
Former roles include Director at Field Trip Health Ltd., Vice President-External Science & Innovation at Forest Laboratories, Inc. and Actavis, Inc. in 2014, Chief Business Officer at IPI Legacy Liquidation Co. from 2018 to 2020, Principal at Celtic Pharma Management LP, and Chief Business Officer at Werewolf Therapeutics, Inc. Education includes undergraduate studies at Stanford University and an MBA from Stanford Graduate School of Business.

Aktiva positioner av Ellen Lubman

FöretagPositionStart
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Direktör/Styrelseledamot 2021-06-01

Tidigare kända positioner av Ellen Lubman

FöretagPositionSlut
IPI LEGACY LIQUIDATION CO Företagsledare/Principal 2020-07-01
FOREST LABORATORIES, INC. Företagsledare/Principal 2014-07-01
Företagsledare/Principal 2008-11-01
REUNION NEUROSCIENCE Direktör/Styrelseledamot -
WEREWOLF THERAPEUTICS, INC. Investor Relations Kontakt -
Se detaljerna i Ellen Lubmans erfarenhet

Ellen Lubmans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

63

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Services

Health Technology

  1. Börsen
  2. Insiders
  3. Ellen Lubman